Product Name

  • Name

    Cefotaxime

  • EINECS 264-299-1
  • CAS No. 63527-52-6
  • Article Data47
  • CAS DataBase
  • Density 1.8 g/cm3
  • Solubility soluble in water
  • Melting Point
  • Formula C16H17N5O7S2
  • Boiling Point
  • Molecular Weight 455.472
  • Flash Point
  • Transport Information
  • Appearance white power
  • Safety
  • Risk Codes
  • Molecular Structure Molecular Structure of 63527-52-6 (Cefotaxime)
  • Hazard Symbols
  • Synonyms Zeefotax;5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid,3-[(acetyloxy)methyl]-7-[[(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-8-oxo-,[6R-[6a,7b(Z)]]-;5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,3-[(acetyloxy)methyl]-7-[[(2Z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-8-oxo-,(6R,7R)- (9CI);Cefabol;Cefotaxime acid;Ceftax;Claforan;Omnatax;Taxim;
  • PSA 227.05000
  • LogP 0.28750

Synthetic route

(Z)-S-benzo[d]thiazol-2-yl 2-(2-aminothiazol-4-yl)-2-(methoxyimino)ethanethioate
80756-85-0

(Z)-S-benzo[d]thiazol-2-yl 2-(2-aminothiazol-4-yl)-2-(methoxyimino)ethanethioate

7-Aminocephalosporanic acid
957-68-6

7-Aminocephalosporanic acid

cefotaxime
63527-52-6

cefotaxime

Conditions
ConditionsYield
With TEA In dichloromethane at 20℃; for 1h; Substitution;95%
With triethylamine In dichloromethane at 20℃; for 1h;95%
Stage #1: (Z)-S-benzo[d]thiazol-2-yl 2-(2-aminothiazol-4-yl)-2-(methoxyimino)ethanethioate; 7-Aminocephalosporanic acid With triethylamine In methanol at 0 - 5℃;
Stage #2: With hydrogenchloride In methanol; water at 0 - 5℃; for 1h; pH=2.3 - 2.5;
Stage #1: (Z)-S-benzo[d]thiazol-2-yl 2-(2-aminothiazol-4-yl)-2-(methoxyimino)ethanethioate; 7-Aminocephalosporanic acid With triethylamine In 1,2-dimethoxyethane at -5 - 0℃;
Stage #2: With hydrogenchloride In 1,2-dimethoxyethane; water for 1h; pH=2.6 - 2.8; Product distribution / selectivity;
diethylthiophosphoryl-(Z)-(2-aminothiazol-4-yl)methoxyimino acetate

diethylthiophosphoryl-(Z)-(2-aminothiazol-4-yl)methoxyimino acetate

7-Aminocephalosporanic acid
957-68-6

7-Aminocephalosporanic acid

cefotaxime
63527-52-6

cefotaxime

Conditions
ConditionsYield
Stage #1: 7-Aminocephalosporanic acid With N,O-bis-(trimethylsilyl)-acetamide In dichloromethane at 20℃; for 1h;
Stage #2: diethylthiophosphoryl-(Z)-(2-aminothiazol-4-yl)methoxyimino acetate In dichloromethane at 20℃; for 8h;
Stage #3: With sodium hydroxide In dichloromethane; water at 15 - 20℃; pH=7.5 - 7.8;
94.4%
Stage #1: 7-Aminocephalosporanic acid With N,O-bis-(trimethylsilyl)-acetamide In DMF (N,N-dimethyl-formamide) at 20 - 25℃;
Stage #2: diethylthiophosphoryl-(Z)-(2-aminothiazol-4-yl)methoxyimino acetate In DMF (N,N-dimethyl-formamide) at 20℃; for 18h;
93.5%
C21H16N6O3S

C21H16N6O3S

7-Aminocephalosporanic acid
957-68-6

7-Aminocephalosporanic acid

cefotaxime
63527-52-6

cefotaxime

Conditions
ConditionsYield
With N,O-bis-(trimethylsilyl)-acetamide In acetonitrile at -5 - 0℃; for 1h; Temperature;93.1%
7-Aminocephalosporanic acid
957-68-6

7-Aminocephalosporanic acid

(2-Amino-thiazol-4-yl)-[(Z)-methoxyimino]-acetic acid 4,6-dimethoxy-[1,3,5]triazin-2-yl ester
207725-19-7

(2-Amino-thiazol-4-yl)-[(Z)-methoxyimino]-acetic acid 4,6-dimethoxy-[1,3,5]triazin-2-yl ester

cefotaxime
63527-52-6

cefotaxime

Conditions
ConditionsYield
With N,O-bis-dimethylsilyl acetamide In acetonitrile at 0 - 5℃; for 1.5h;75.4%
7-[4-bromo-2(Z)-methoxyimino-3-oxobutyramido]-cephalosporanic acid

7-[4-bromo-2(Z)-methoxyimino-3-oxobutyramido]-cephalosporanic acid

thiourea
17356-08-0

thiourea

cefotaxime
63527-52-6

cefotaxime

Conditions
ConditionsYield
Stage #1: 7-[4-bromo-2(Z)-methoxyimino-3-oxobutyramido]-cephalosporanic acid; thiourea With sodium acetate In dichloromethane; water for 2.5 - 3.5h;
Stage #2: With hydrogenchloride In tetrahydrofuran; water pH=2.8;
40.3%
7-Aminocephalosporanic acid
957-68-6

7-Aminocephalosporanic acid

2-(2-aminothiazol-4-yl)-2-(methoxy)iminoacetic acid
64485-90-1

2-(2-aminothiazol-4-yl)-2-(methoxy)iminoacetic acid

cefotaxime
63527-52-6

cefotaxime

Conditions
ConditionsYield
(i) DCC, CH2Cl2, (ii) /BRN= 622638/, Et3N, (iii) aq. HCO2H; Multistep reaction;
pyvaloyloxymethyl 7β-<2-(2-aminothiazol-4-yl)-(Z)-methoxyiminoacetamido>-3-acetoxymethyl-3-cephem-4-carboxylate
65243-53-0

pyvaloyloxymethyl 7β-<2-(2-aminothiazol-4-yl)-(Z)-methoxyiminoacetamido>-3-acetoxymethyl-3-cephem-4-carboxylate

A

cefotaxime
63527-52-6

cefotaxime

B

(2R,6R,7R)-3-Acetoxymethyl-7-{2-(2-amino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-3-ene-2-carboxylic acid
126747-48-6

(2R,6R,7R)-3-Acetoxymethyl-7-{2-(2-amino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-3-ene-2-carboxylic acid

C

(2R,6R,7R)-3-Acetoxymethyl-7-{2-(2-amino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-3-ene-2-carboxylic acid 2,2-dimethyl-propionyloxymethyl ester

(2R,6R,7R)-3-Acetoxymethyl-7-{2-(2-amino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-3-ene-2-carboxylic acid 2,2-dimethyl-propionyloxymethyl ester

Conditions
ConditionsYield
With water In N,N-dimethyl-formamide at 37℃; Rate constant; phosphate buffer, var. pH;
ethyl 2-(2-aminothiazol-4-yl)-2-(anti)-methoxyiminoacetate
64485-88-7

ethyl 2-(2-aminothiazol-4-yl)-2-(anti)-methoxyiminoacetate

cefotaxime
63527-52-6

cefotaxime

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: Et3N / dimethylformamide / 3 h
2: aq. NaOH / dioxane / 0.5 h / Heating
3: (i) DCC, CH2Cl2, (ii) /BRN= 622638/, Et3N, (iii) aq. HCO2H
View Scheme
(Z)-γ-bromo-β-oxo-α-methoxyiminobutyric acid ethyl ester
65872-39-1

(Z)-γ-bromo-β-oxo-α-methoxyiminobutyric acid ethyl ester

cefotaxime
63527-52-6

cefotaxime

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: ethanol; H2O / 1 h / 20 °C
2: Et3N / dimethylformamide / 3 h
3: aq. NaOH / dioxane / 0.5 h / Heating
4: (i) DCC, CH2Cl2, (ii) /BRN= 622638/, Et3N, (iii) aq. HCO2H
View Scheme
ethyl (Z)-2-(methoxyimino)-2-[2-(triphenylmethyl)-aminothiazol-4-yl]acetate
64485-89-8

ethyl (Z)-2-(methoxyimino)-2-[2-(triphenylmethyl)-aminothiazol-4-yl]acetate

cefotaxime
63527-52-6

cefotaxime

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: aq. NaOH / dioxane / 0.5 h / Heating
2: (i) DCC, CH2Cl2, (ii) /BRN= 622638/, Et3N, (iii) aq. HCO2H
View Scheme
C15H16ClN3O8S

C15H16ClN3O8S

thiourea
17356-08-0

thiourea

cefotaxime
63527-52-6

cefotaxime

Conditions
ConditionsYield
Stage #1: C15H16ClN3O8S; thiourea With triethylamine In tetrahydrofuran; water at 20 - 25℃; for 4h; pH=7.5;
Stage #2: With hydrogenchloride In water at 15 - 20℃; for 0.5h; pH=3 - 4.2;
C15H16ClN3O8S
71754-15-9

C15H16ClN3O8S

thiourea
17356-08-0

thiourea

cefotaxime
63527-52-6

cefotaxime

Conditions
ConditionsYield
Stage #1: C15H16ClN3O8S; thiourea With sodium acetate In tetrahydrofuran; water at 20℃; for 1h;
Stage #2: With hydrogenchloride In tetrahydrofuran; water at 10℃; for 1h; pH=2.5;
7β-[2-(2-chloroacetamidothiazol-4-yl)-(Z)-2-methoxyiminoacetamido]-3-acetoxymethyl-3-cephem-4-carboxylic acid
64486-19-7

7β-[2-(2-chloroacetamidothiazol-4-yl)-(Z)-2-methoxyiminoacetamido]-3-acetoxymethyl-3-cephem-4-carboxylic acid

cefotaxime
63527-52-6

cefotaxime

Conditions
ConditionsYield
Stage #1: 7β-[2-(2-chloroacetamidothiazol-4-yl)-(Z)-2-methoxyiminoacetamido]-3-acetoxymethyl-3-cephem-4-carboxylic acid With water; sodium carbonate; thiourea; isopropyl alcohol at 20 - 30℃;
Stage #2: With hydrogenchloride; water In isopropyl alcohol at 20 - 30℃; for 2h; pH=2.7 - 3.0;
(Z)-S-benzo[d]thiazol-2-yl 2-(2-aminothiazol-4-yl)-2-(methoxyimino)ethanethioate
80756-85-0

(Z)-S-benzo[d]thiazol-2-yl 2-(2-aminothiazol-4-yl)-2-(methoxyimino)ethanethioate

7-Aminocephalosporanic acid
957-68-6

7-Aminocephalosporanic acid

A

cefotaxime
63527-52-6

cefotaxime

B

2-Mercaptobenzothiazole
149-30-4

2-Mercaptobenzothiazole

Conditions
ConditionsYield
Stage #1: (Z)-S-benzo[d]thiazol-2-yl 2-(2-aminothiazol-4-yl)-2-(methoxyimino)ethanethioate; 7-Aminocephalosporanic acid With sodium 2-ethylhexanoate In water; acetonitrile at 6 - 8℃; for 12h;
Stage #2: In water; acetonitrile pH=2.5 - 3.0;
4-chloro-2-methoxyimino-3-oxo-butyric acid
111230-59-2

4-chloro-2-methoxyimino-3-oxo-butyric acid

thiourea
17356-08-0

thiourea

7-Aminocephalosporanic acid
957-68-6

7-Aminocephalosporanic acid

cefotaxime
63527-52-6

cefotaxime

Conditions
ConditionsYield
Stage #1: 4-chloro-2-methoxyimino-3-oxo-butyric acid With phosphorus pentachloride In dichloromethane at -5 - 0℃; for 1h;
Stage #2: 7-Aminocephalosporanic acid With ammonia In water; acetone at -5 - 0℃; for 0.5 - 0.666667h; pH=6.5 - 7;
Stage #3: thiourea With sodium acetate In water; acetone at 18 - 20℃; for 1h;
C13H11N5O2S2

C13H11N5O2S2

7-Aminocephalosporanic acid
957-68-6

7-Aminocephalosporanic acid

cefotaxime
63527-52-6

cefotaxime

Conditions
ConditionsYield
Stage #1: C13H11N5O2S2; 7-Aminocephalosporanic acid With sodium hydrogensulfite; triethylamine In ethanol; dichloromethane; isopropyl alcohol at 5℃; pH=7 - 8;
Stage #2: With hydrogenchloride In water; acetone at 10℃; for 1.5h; pH=2.5; Temperature;
N,O-bis-(trimethylsilyl)-acetamide
10416-59-8

N,O-bis-(trimethylsilyl)-acetamide

D-(-)-2-formyloxy-2-phenylacetyl chloride
57079-45-5

D-(-)-2-formyloxy-2-phenylacetyl chloride

7-amino-3-(4-methylthiazolyl)-3-cephem-4-carboxylic acid

7-amino-3-(4-methylthiazolyl)-3-cephem-4-carboxylic acid

ethyl acetate
141-78-6

ethyl acetate

cefotaxime
63527-52-6

cefotaxime

Conditions
ConditionsYield
at 20℃;
2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetic acid
91868-79-0

2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetic acid

cefotaxime
63527-52-6

cefotaxime

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 1,8-diazabicyclo[5.4.0]undec-7-ene / N,N-dimethyl-formamide / 2.5 h / 2 - 25 °C
2: N,O-bis-(trimethylsilyl)-acetamide / acetonitrile / 1 h / -5 - 0 °C
View Scheme
cefotaxime
63527-52-6

cefotaxime

cefotaxime sodium salt
64485-93-4

cefotaxime sodium salt

Conditions
ConditionsYield
With sodium hydrogencarbonate In ethanol Substitution;95.4%
With sodium isooctanoate; sodium sulfite In water; acetone at 5 - 10℃; for 0.5h;95%
With triethylamine; sodium 2-ethylhexanoic acid In methanol; ethyl acetate88.7%
cefotaxime
63527-52-6

cefotaxime

chloroacetyl chloride
79-04-9

chloroacetyl chloride

7β-[2-(2-chloroacetamidothiazol-4-yl)-(Z)-2-methoxyiminoacetamido]-3-acetoxymethyl-3-cephem-4-carboxylic acid
64486-19-7

7β-[2-(2-chloroacetamidothiazol-4-yl)-(Z)-2-methoxyiminoacetamido]-3-acetoxymethyl-3-cephem-4-carboxylic acid

Conditions
ConditionsYield
In N,N-dimethyl acetamide at 20℃; for 1h;90.2%
cefotaxime
63527-52-6

cefotaxime

diazodiphenylmethane
908093-98-1

diazodiphenylmethane

benzhydryl (6R,7R,Z)-3-(acetoxymethyl)-7-(2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylate

benzhydryl (6R,7R,Z)-3-(acetoxymethyl)-7-(2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylate

Conditions
ConditionsYield
With toluene-4-sulfonic acid In water; acetonitrile at 20℃; for 0.75h; pH=3; Inert atmosphere;80%
cefotaxime
63527-52-6

cefotaxime

5-[(4-methylquinolin-2-yloxy)methyl]-1,3,4-thiadiazole-2-thiol
239468-67-8

5-[(4-methylquinolin-2-yloxy)methyl]-1,3,4-thiadiazole-2-thiol

7-{[(2-aminothiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[5-[(4-methylquinolin-2-yloxy)methyl]-1,3,4-thiadiazol-2-ylthio]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

7-{[(2-aminothiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[5-[(4-methylquinolin-2-yloxy)methyl]-1,3,4-thiadiazol-2-ylthio]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

Conditions
ConditionsYield
With boron trifluoride diethyl etherate In acetic acid for 0.0333333h; Condensation; microwave irradiation;58%
cefotaxime
63527-52-6

cefotaxime

5-[(quinolin-8-yloxy)methyl]-1,3,4-thiadiazole-2-thiol
239468-65-6

5-[(quinolin-8-yloxy)methyl]-1,3,4-thiadiazole-2-thiol

7-{[(2-aminothiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[5-[(quinolin-8-yloxy)methyl]-1,3,4-thiadiazol-2-ylthio]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

7-{[(2-aminothiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[5-[(quinolin-8-yloxy)methyl]-1,3,4-thiadiazol-2-ylthio]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

Conditions
ConditionsYield
With boron trifluoride diethyl etherate In acetic acid for 0.0166667h; Condensation; microwave irradiation;54%
cefotaxime
63527-52-6

cefotaxime

furane-2-monocarboxylic acid
4741-45-1

furane-2-monocarboxylic acid

ceftiofur
80370-57-6

ceftiofur

Conditions
ConditionsYield
With methanesulfonic acid; sulfuric acid In acetonitrile at 15 - 20℃;54%
With methanesulfonic acid In dichloromethane at 23 - 27℃;47%
With methanesulfonic acid In ethyl acetate at 30℃;47%
cefotaxime
63527-52-6

cefotaxime

5-[(5-methyl-1,3,4-thiadiazol-2-ylthio)methyl]-1,3,4-thiadiazole-2-thiol
202116-95-8

5-[(5-methyl-1,3,4-thiadiazol-2-ylthio)methyl]-1,3,4-thiadiazole-2-thiol

7-{[(2-aminothiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[5-[(5-methyl-1,3,4-thiadiazol-2-ylthio)methyl]-1,3,4-thiadiazol-2-ylthio]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

7-{[(2-aminothiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[5-[(5-methyl-1,3,4-thiadiazol-2-ylthio)methyl]-1,3,4-thiadiazol-2-ylthio]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

Conditions
ConditionsYield
With boron trifluoride diethyl etherate In acetic acid for 0.025h; Condensation; microwave irradiation;52%
cefotaxime
63527-52-6

cefotaxime

5-[(tetrazol-1-yl)methyl]-1,3,4-thiadiazole-2-thiol
202116-96-9

5-[(tetrazol-1-yl)methyl]-1,3,4-thiadiazole-2-thiol

7-{[(2-aminothiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[5-[(tetrazol-1-yl)methyl]-1,3,4-thiadiazol-2-ylthio]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

7-{[(2-aminothiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[5-[(tetrazol-1-yl)methyl]-1,3,4-thiadiazol-2-ylthio]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

Conditions
ConditionsYield
With boron trifluoride diethyl etherate In acetic acid for 0.025h; Condensation; microwave irradiation;48%
cefotaxime
63527-52-6

cefotaxime

Vilsmeier reagent
3724-43-4, 149409-22-3

Vilsmeier reagent

C33H34N10O14S4

C33H34N10O14S4

Conditions
ConditionsYield
at 35℃; for 2.5h;35.8%
cefotaxime
63527-52-6

cefotaxime

N-methyl-N-trimethylsilyl-2,2,2-trifluoroacetamide
24589-78-4

N-methyl-N-trimethylsilyl-2,2,2-trifluoroacetamide

C19H25N5O7S2Si
104498-86-4

C19H25N5O7S2Si

Conditions
ConditionsYield
In dichloromethane at 40℃;
cefotaxime
63527-52-6

cefotaxime

N-methyl-N-trimethylsilyl-2,2,2-trifluoroacetamide
24589-78-4

N-methyl-N-trimethylsilyl-2,2,2-trifluoroacetamide

C20H31N5O6S2Si2

C20H31N5O6S2Si2

Conditions
ConditionsYield
In dichloromethane for 1h;
cefotaxime
63527-52-6

cefotaxime

(6R,7R)-7-{2-(2-Amino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-3-bromomethyl-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid

(6R,7R)-7-{2-(2-Amino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-3-bromomethyl-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid

Conditions
ConditionsYield
In dichloromethane
cefotaxime
63527-52-6

cefotaxime

(6R,7R)-7-{2-(2-Amino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-3-iodomethyl-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid
86070-92-0

(6R,7R)-7-{2-(2-Amino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-3-iodomethyl-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid

Conditions
ConditionsYield
In dichloromethane
With trimethylsilyl iodide; N-methyl-N-trimethylsilyl-2,2,2-trifluoroacetamide In dichloromethane at 20℃; for 0.5h; Substitution;
cefotaxime
63527-52-6

cefotaxime

2,3-cyclopentenopyridine
533-37-9

2,3-cyclopentenopyridine

Conditions
ConditionsYield
With potassium iodide In water at 70℃;
cefotaxime
63527-52-6

cefotaxime

N-methyl-N-trimethylsilyl-2,2,2-trifluoroacetamide
24589-78-4

N-methyl-N-trimethylsilyl-2,2,2-trifluoroacetamide

7β-<2-(2-aminothiazol-4yl)-2-(Z)-methoximinoacetamide>-3-iodomethyl-2-<(trimethylsilyloxy)carbonyl>cephalosporin
83421-24-3

7β-<2-(2-aminothiazol-4yl)-2-(Z)-methoximinoacetamide>-3-iodomethyl-2-<(trimethylsilyloxy)carbonyl>cephalosporin

Conditions
ConditionsYield
Stage #1: cefotaxime; N-methyl-N-trimethylsilyl-2,2,2-trifluoroacetamide In dichloromethane for 1h; Iodination;
Stage #2: With trimethylsilyl iodide In dichloromethane for 0.5h; Condensation;
cefotaxime
63527-52-6

cefotaxime

cefpodoxime proxetil
87239-81-4

cefpodoxime proxetil

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 90.2 percent / N,N-dimethyl-acetamide / 1 h / 20 °C
2: 65 percent / aq. NaHCO3; CaCl2*2H2O / 1.25 h / 70 °C
3: 2.4 g / dicyclohexylamine / N,N-dimethyl-acetamide / 0.75 h / 0 - 5 °C
4: 1.44 g / thiourea / N,N-dimethyl-acetamide / 3 h / 20 °C
View Scheme
cefotaxime
63527-52-6

cefotaxime

7β-[2-(2-chloroacetamidothiazol-4-yl)-(Z)-2-methoxyiminoacetamido]-3-methoxymethyl-3-cephem-4-carboxylic acid
82618-67-5

7β-[2-(2-chloroacetamidothiazol-4-yl)-(Z)-2-methoxyiminoacetamido]-3-methoxymethyl-3-cephem-4-carboxylic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 90.2 percent / N,N-dimethyl-acetamide / 1 h / 20 °C
2: 65 percent / aq. NaHCO3; CaCl2*2H2O / 1.25 h / 70 °C
View Scheme
cefotaxime
63527-52-6

cefotaxime

(6R,7R)-7-{2-[2-(2-Chloro-acetylamino)-thiazol-4-yl]-2-[(Z)-methoxyimino]-acetylamino}-3-methoxymethyl-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid 1-isopropoxycarbonyloxy-ethyl ester
620962-96-1

(6R,7R)-7-{2-[2-(2-Chloro-acetylamino)-thiazol-4-yl]-2-[(Z)-methoxyimino]-acetylamino}-3-methoxymethyl-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid 1-isopropoxycarbonyloxy-ethyl ester

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 90.2 percent / N,N-dimethyl-acetamide / 1 h / 20 °C
2: 65 percent / aq. NaHCO3; CaCl2*2H2O / 1.25 h / 70 °C
3: 2.4 g / dicyclohexylamine / N,N-dimethyl-acetamide / 0.75 h / 0 - 5 °C
View Scheme
cefotaxime
63527-52-6

cefotaxime

C19H21N7O5S3

C19H21N7O5S3

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: MSTFA; TMSI / CH2Cl2 / 0.5 h / 20 °C
2: 0.10 g / MSTFA / acetonitrile; tetrahydrofuran / 20 h / 20 °C
View Scheme
cefotaxime
63527-52-6

cefotaxime

C20H23N7O5S3

C20H23N7O5S3

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: MSTFA; TMSI / CH2Cl2 / 0.5 h / 20 °C
2: MSTFA / acetonitrile; tetrahydrofuran / 20 h / 20 °C
View Scheme
cefotaxime
63527-52-6

cefotaxime

C22H20N8O5S2

C22H20N8O5S2

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: CH2Cl2 / 1 h
1.2: Me3SiI / CH2Cl2 / 0.5 h
2.1: acetonitrile; tetrahydrofuran / 16 h / 20 °C
View Scheme

Cefotaxime Specification

The Cefotaxime with CAS registry number of 63527-52-6 is also known as Cefotaximum. The IUPAC name is (6R,7R)-3-(Acetyloxymethyl)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid. Its EINECS registry number is 264-299-1. In addition, the formula is C16H17N5O7S2 and the molecular weight is 455.47. This chemical is a white power.

Physical properties about Cefotaxime are: (1)ACD/LogP: 1.20; (2)# of Rule of 5 Violations: 1; (3)ACD/BCF (pH 5.5): 1; (4)ACD/BCF (pH 7.4): 1; (5)ACD/KOC (pH 5.5): 1; (6)ACD/KOC (pH 7.4): 1; (7)#H bond acceptors: 12; (8)#H bond donors: 4; (9)#Freely Rotating Bonds: 8; (10)Index of Refraction: 1.778; (11)Molar Refractivity: 105.95 cm3; (12)Molar Volume: 252.8 cm3; (13)Surface Tension: 81.2 dyne/cm; (14)Density: 1.8 g/cm3.

Preparation of Cefotaxime: it is prepared by reaction of cephalosporin C. Firstly, cefotaxime is crystallizated after cracking, silicon esterification, condensation and hydrolysis. Secondly, add sodium acetate to get sodium. Product is obtained after bleaching, sterile filtration and crystallization.

Uses of Cefotaxime: it is used as antibacterial drugs and is a semi-synthetic oxime-type cephalosporins. It is used for infections of the respiratory tract, skin, bones, joints, urogenital system, meningitis, and septicemia. This chemical is used to produce 7b-(2-(2-Aminothiazol-4-yl)-(Z)-2-methoxyiminoacetamido)-3-acetoxymethyl-3-cephem-4-carboxylic acid sodium salt. The reaction occurs with reagent aq. NaHCO3 and solvent ethanol. The yield is about 95.4%.

Cefotaxime is used to produce 7b-(2-(2-Aminothiazol-4-yl)-(Z)-2-methoxyiminoacetamido)-3-acetoxymethyl-3-cephem-4-carboxylic acid sodium salt.

You can still convert the following datas into molecular structure:
1. SMILES: O=C2N1/C(=C(\CS[C@@H]1[C@@H]2NC(=O)C(=NOC)c3nc(sc3)N)COC(=O)C)C(=O)O
2. InChI: InChI=1/C16H17N5O7S2/c1-6(22)28-3-7-4-29-14-10(13(24)21(14)11(7)15(25)26)19-12(23)9(20-27-2)8-5-30-16(17)18-8/h5,10,14H,3-4H2,1-2H3,(H2,17,18)(H,19,23)(H,25,26)/t10-,14-/m1/s1
3. InChIKey: GPRBEKHLDVQUJE-QMTHXVAHBP

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View